Home | Volume 8

Huntington’s disease: pre-clinical models to therapy using genetically-modified immunoisolated cells and lentiviral vectors

Dr. Dwaine F. Emerich et. al.

Download as PDF : 05. Emerich&Borlongan, 45-5.pdf : 101687 bytes


Previous Article: Radioprotective antioxidant gene therapy: Potential mechanisms of action
Next Article: Histone deacetylase inhibitors: promising candidates for chemotherapeutic drugs
The Publication:
Huntington’s disease: pre-clinical models to therapy using genetically-modified immunoisolated cells and lentiviral vectors
is not formatted in HTML just yet, but will be available very soon!
Please view as a PDF: 05. Emerich&Borlongan, 45-5.pdf in the meantime.